What's New
Update: new model for patients with primary RPS taking into consideration the improved outcome over time and the case-volume effect.
Aggiornamento: nuovo modello per pazienti con sarcomi primitivi del retroperitoneo che tiene in considerazione del miglioramento della prognosi osservata negli anni recenti e l’effetto del volume del centro.
About SARCULATOR Android App
This app is meant to be used only by physicians and it is not meant to make clinical decisions (the clinical usefulness of the two models has not been tested) but to be used as an informative tool to improve the predictive capability of a physician.
Two kinds of predictions are possible:
- RPS: 5-year overall survival (OS) and 5-year disease-free survival (DFS) in primary resected retroperitoneal sarcoma (RPS) patients. .
- STS: 5- and 10-year overall survival (OS) and cumulative incidence of distant metastasis (CCI of DM) in primary resected extremity STS patients.
Other Information:
Download
This release of SARCULATOR Android App available in 2 variants. Please select the variant to download. Please read our FAQ to find out which variant is suitable for your Android device based on Screen DPI and Processor Architecture.
All Versions
If you are looking to download other versions of SARCULATOR Android App, We have 3 versions in our database. Please select one of them below to download.
